Introduction
============

The number of spinal surgeries aiming to correct major spinal deformities or degenerative changes has been increasing. The main cause of this increase is considered to be the increases in the life expectancy as well as the rate of ageing (the number of individuals \>65 years of age) of the general population \[[@b1-asj-2018-12-3-459]\]. Patients planning to undergo spinal surgeries, such as spinal fusion, experience complications, such as a delay in discharge from hospital, perioperative blood loss, and need for repeat surgery, particularly when they are overweight \[[@b2-asj-2018-12-3-459],[@b3-asj-2018-12-3-459]\]. The estimated intraoperative blood loss in spinal fusion surgeries is 907±775 mL for posterior spinal fusion, 323±171 mL for anterior spinal fusion, and 1,277±825 mL for combined procedures \[[@b4-asj-2018-12-3-459]\], which illustrates the fact that there is usually massive bleeding in such surgeries.

Minimally invasive spinal surgeries have long-term outcomes similar to those of open spinal procedures \[[@b5-asj-2018-12-3-459],[@b6-asj-2018-12-3-459]\]. There are fewer short-term complications in minimally invasive surgeries than in open procedures, such as decreased need for blood transfusion during surgery, decreased pain postoperatively, shorter hospitalization time, and decreased volume of intraoperative blood loss \[[@b5-asj-2018-12-3-459],[@b7-asj-2018-12-3-459],[@b8-asj-2018-12-3-459]\]. Nevertheless, blood loss as a complication of spinal surgeries is a concern in both types of procedures. Spinal epidural hematoma may also occur in patients undergoing multilevel lumbar interventions or in those with coagulopathy disorders \[[@b9-asj-2018-12-3-459]\]. Blood transfusion is required to replace intraoperative blood loss, but there are several transfusion-related morbidities, including acute lung injury and the transmission of infections. High financial costs and mortality are also possible consequences. These complications limit the routine use of autologous transfusion \[[@b10-asj-2018-12-3-459]-[@b16-asj-2018-12-3-459]\]. The importance of reserving blood in any medical procedure is evident, and several blood-sparing techniques, including the administration of epidural blockade, desmopressin, aprotinin, tranexamic acid, epsilon-aminocaproic acid, estrogen, bone wax, fibrin sealants, hemostatic sponges, blood-saving techniques, acute hemodilution, and planned autologous transfusion, are recommended to decrease intraoperative bleeding or the need for transfusion \[[@b17-asj-2018-12-3-459],[@b18-asj-2018-12-3-459]\].

The vertebral venous plexus is a large valve-less network of vertebral veins that regulates venous drainage of the spinal cord \[[@b19-asj-2018-12-3-459]\], and similar to other venous systems throughout the body, external pressure can affect its blood flow \[[@b20-asj-2018-12-3-459],[@b21-asj-2018-12-3-459]\]. In our case, the environmental pressure is intra-abdominal pressure, and full bowels can increase intra-abdominal pressure. In the present study, we evaluated whether lowering intra-abdominal pressure via the mechanical evacuation of the gastro-intestinal tract could lower abdominal venous pressure and consequently decrease perioperative bleeding.

Materials and Methods
=====================

This randomized clinical trial study (NCT02493894) was conducted from February 2012 until June 2014 at the neurosurgery ward of Alzahra Hospital, one of the teaching hospitals of the Isfahan University of Medical Sciences. In this study, 108 patients who were admitted to our hospital and underwent spinal surgery (fusion and instrumentation) with a pedicular screw because of spinal column instability, degenerative changes, and canal stenosis were included. The indication for surgery was determined by an experienced neurosurgeon, and the decision for surgery was based on clinical findings, imaging data, and guidelines and reference sources for neurosurgery. Patients with a history of trauma, malignancy, previous spinal surgery, coagulation disorders, active infectious disease, gastrointestinal problems, or severe movement disorders were excluded from the study. Patients receiving anticoagulants or anti-platelet drugs or any medication affecting coagulation were not included. In patients receiving such medications, the surgery was postponed until the medication was discontinued and its effects were diminished. The patients exhibited normal bowel habits during 6 months prior to the surgery.

During this prospective study, the patients were randomly divided into two groups: treatment group (n=54) and control group (n=54) ([Fig. 1](#f1-asj-2018-12-3-459){ref-type="fig"}). The patients in both the groups were matched for age; sex; and current morbidity, including diabetes and hypertension; anemia; and preoperative hemoglobin (Hb) levels. Written informed consent regarding the therapeutic plan and the probable side effects was obtained from all patients in the treatment group. The ethics committee of the Isfahan University of Medical Sciences approved the protocol for this study (IRB approval no., 393618), and the study was conducted in accordance with the principles of the Declaration of Helsinki.

The patients' characteristics, including body mass index (BMI), previous medical history (diabetes and hypertension), and Hb level were recorded. In the treatment group, the patients received a liquid diet for 24 hours, followed by polyethylene glycol (PEG) solution (80 g/L) every 8 hours for 24 hours. After 48 hours, the bowels were mechanically prepared for the procedure. The operation was performed with the patients in the prone position on a standard surgery table. In all patients, laminectomy was performed, but a facetectomy was also required in 10% of the patients. None of the patients required posterior lumbar interbody fusion or transforaminal lumbar interbody fusion. All patients received general anesthesia in a similar manner. In the postoperative anesthesia care unit (PACU), vital signs (blood pressure, pulse, respiration, pulse oximetry, and adequate answering) were monitored every 15 minutes by a consultant. Patients were discharged from the PACU when vital signs were normalized.

In both the groups, the operative time and volume of bleeding (in cm^3^) were precisely recorded by the surgical and anesthetics team. The need for blood transfusion during surgery was determined on the basis of preoperative Hb level and the volume of bleeding during surgery and was calculated according to anesthesiology and surgical standards using the following formula \[[@b22-asj-2018-12-3-459]\]:
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Immediately following the surgery, the exact rate of bleeding during the operation (in mL), operative time, approximate transfusion rate, and fusion level were recorded. The maximum level of fusion performed was 4. The volume of bleeding in the hemovac drain was recorded 24 hours and 48 hours postoperatively. The patients' Hb levels were measured in 24- and 48-hour intervals after the operation.

After ambulating the patients, they were discharged from the hospital. The duration before the patients were mobilized and the total duration of hospitalization were recorded. The successful outcome of the operation was evaluated on the basis of the patients' clinical conditions and using imaging modalities: computed tomography scans and X-ray radiographs.

1. Statistical analysis
-----------------------

The data were analyzed in the IBM SPSS software ver. 20.0 (IBM Corp., Armonk, NY, USA), using chi-square test and independent *t*-test. Repeated measures analysis of covariance (ANCOVA) and Pearson's correlation tests were used to determine confounder variables that could influence perioperative bleeding in three stages (during surgery, 24 hours after surgery, and 48 hours after surgery). Adjustment for multiple comparisons was performed using Bonferroni test. Repeated measures ANCOVA was used after adjusting confounding variables. All *p*\<0.05 were considered as indicating a statistically significant difference.

Results
=======

In this study, a total of 108 patients who were candidates for the fusion and instrumentation of the lumbar spine, were divided into two groups with 54 patients each. The rates of mortality and morbidity (surgical and anesthetic complications), evaluated at discharge and a week after discharge, were zero. *T*-tests revealed less intraoperative bleeding, less surgical transfusion amount, and reduced operation time in the treatment group than in the control group ([Table 1](#t1-asj-2018-12-3-459){ref-type="table"}). Regardless of the allocated group, Pearson's correlation tests revealed associations among intraoperative bleeding and the following variables: age (*p*=0.001), BMI (*p*\<0.001), preoperative Hb (*p*=0.001), operative time (*p*\<0.001), transfusion amount (*p*=0.000), hospitalization time (*p*\<0.001), and postoperative 24- and 48-hour bleeding (*p*\<0.001). Furthermore, the mobilization of patients prior to discharge was significantly correlated with hospitalization time (*p*=0.000).

After adjusting covariate variables, including age, sex, BMI, presence of diabetes, preoperative Hb, operative time, and transfusion amount, the repeated measures ANCOVA revealed that bleeding in the three stages was significantly different (*p*\<0.01) and that the volume of bleeding showed a near-significant trend in the treatment group compared with that in the control group (*p*=0.056). In addition, the diabetic females showed the highest bleeding rate in both the groups (*p*=0.03), and the bleeding rate was higher in the patients with higher BMI (*p*=0.02). The operative time was longer in the patients in both the groups (*p*=0.001).

Discussion
==========

Intra-abdominal pressure is affected by the abdominal content. Hypothetically, decreasing the intra-abdominal contents should decrease the intra-abdominal pressure. Pressure on the abdominal contents would be transmitted to the inferior vena cava and then to the epidural venous system, which could cause increased bleeding during operation \[[@b20-asj-2018-12-3-459]\]. Releasing pressure from the intraabdominal venous plexus should, therefore, improve flow in the venous system surrounding the spine because of the close network with the Batson's plexus. In this study, the possible effect of mechanical gastrointestinal evacuation on surgical bleeding during lumbar spine fusion and instrumentation surgeries was evaluated for the first time. In univariate analysis, intraoperative bleeding and operative time were significantly higher in the treatment group than in the control group; however, in the repeated measures ANCOVA, a near-significant trend was observed. Although a study by Glickman et al. \[[@b23-asj-2018-12-3-459]\] has evaluated the efficacy of the regional usage of synthetic PEG in anastomoses sites to reduce local bleeding, our extensive search of the literature yielded no study similar to ours.

Recent research studies have been conducted on the beneficial aspects of PEG as a tissue-compatible reagent for the prevention of adhesion after laminectomy \[[@b24-asj-2018-12-3-459]\] and as a carrier of regeneration-prompting molecules in spinal cord injuries \[[@b25-asj-2018-12-3-459]\]. The oral administration of PEG in patients suffering from spinal injuries has also been noted in the setting of bowel preparation for colonoscopy \[[@b26-asj-2018-12-3-459]\] and the treatment of neurological bowel dysfunction after spinal cord injuries \[[@b27-asj-2018-12-3-459]\]. Our results support the administration of PEG for bowel evacuation to decrease the volume of intraoperative bleeding during spinal surgeries and to decrease the need for blood transfusion. A study by Stokes et al. \[[@b15-asj-2018-12-3-459]\] n bleeding-related complications in a group of surgical patients undergoing various surgeries (thoracic, vascular, hip and knee replacement, general, reproductive organ, and spinal surgeries) has demonstrated that the highest cost per hospitalization was associated with bleeding-related complications of spinal surgeries.

Excessive blood loss is defined as a loss of more than one volume of the total blood or 60 mL/kg in adults in a period of less than one day \[[@b28-asj-2018-12-3-459]\]. A study by Stokes et al. \[[@b15-asj-2018-12-3-459]\] has shown that 14.3% of patients who underwent spinal surgery required blood product transfusions and 0.3% required interventions to control bleeding. A study by Thompson et al. \[[@b29-asj-2018-12-3-459]\] on patients who underwent posterior spinal instrumentation and fusion has revealed that excessive blood loss was statistically associated with the number of levels fused, operative time, and the number of screws. They have also found that the number of levels fused during spinal surgery was the strongest predictive factor for intraoperative blood loss. Similar, our data indicates that higher levels of fusion and longer operative time were associated with further blood loss in spinal surgeries. Other factors influencing the risk of intraoperative bleeding could be older age, obesity, Hb levels before operation, and the presence of diabetes and hypertension. Similar data from another study has demonstrated that age, a history of prior surgery, or the presence of underlying disease (diabetes and chronic obstructive pulmonary disease) were associated with a higher risk of intraoperative bleeding \[[@b15-asj-2018-12-3-459]\]. Interestingly, we noted that diabetic women had the highest risk of massive blood loss during spinal surgery, which should be considered by surgeons when managing this group of patients. Zheng et al. \[[@b30-asj-2018-12-3-459]\] have reported that among patients who underwent spinal surgeries, the operative time was associated with the number of levels fused, the diagnosis of degenerative scoliosis, and being overweight. Similarly, the study of Zheng et al. \[[@b30-asj-2018-12-3-459]\] has also illustrated that higher preoperative Hb levels, body weight, and the number of levels fused were the major risk factors predictive of intraoperative bleeding. Patients who experienced more bleeding during the operation experienced more bleeding episodes 24 and 48 hours after the surgery.

Conclusions
===========

Our statistical analysis illustrated that preoperative gastrointestinal tract evacuation by PEG administration can decrease intraoperative bleeding in spinal surgeries as well as reduce operative time and the need for blood transfusion. Older age, obesity, operative time, and underlying morbidity were also associated with higher intraoperative bleeding. Our data demonstrate that patients whose gastrointestinal tracts were evacuated before surgery required less transfusion than patients in the control group. Therefore, we conclude that PEG usage could be a means to reduce blood transfusion rates. However, more evidence is imperative to substantiate our findings that PEG reduces blood transfusion rates in spinal or other surgical procedures.
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Characteristics of patients who underwent spinal surgery

  Characteristic                                   Treatment group   Control group   Total           *p*-value
  ------------------------------------------------ ----------------- --------------- --------------- -----------
  Sex                                                                                                0.147
   Male                                            20 (37)           27 (50)         47 (43.9)       
   Female                                          34 (63)           27 (50)         61 (56.1)       
   Total                                           54 (100)          54 (100)        108 (100)       
  Age (yr)                                         55.39±12.67       57.09±11.85     56.18±12.2      0.474
  Body mass index (kg/m^2^)                        24.68±21.10       24.59±2.80      24.58±2.51      0.845
  Diabetes                                         12 (22)           15 (27)         27 (25)         0.502
  Hypertension                                     14 (26)           16 (28)         30 (28)         0.665
  Preoperative Hb                                  13.08±0.84        13.16±1.05      13.1±0.96       0.666
  Postoperative Hb day 1                           11.7±0.99         11.56±1.11      11.6±1.05       0.490
  Postoperative Hb 48 hr                           11.7±0.95         11.37±1.0       11.5±1          0.086
  Need for transfusion (mL)                        370±0.652         870±1.19                        0.008
  No. of fusion levels                                                                               1.000
   2                                               16 (29.6)         16 (29.6)       32 (29.6)       
   3                                               27 (50.0)         27 (50.0)       54 (50.0)       
   4                                               11 (20.4)         11 (20.4)       22 (20.4)       
  Operative time (hr)                              2.49±0.62         2.79±0.67       2.6±0.66        0.016
  Intraoperative bleeding (mL)                     784.63±291.5      921.39±472.99   849.77±396.62   0.043
  Postoperative bleeding 24 hr (mL)                98.15±45.64       110.93±56.08    104.05±51.05    0.197
  Postoperative bleeding 48 hr (mL)                119.25±74.57      139.35±102.28   129.12±89.40    0.249
  Hospitalization time before mobilization (day)   1.70±0.571        1.70±0.633      1.70±0.60       1.000
  Postoperative hospitalization time (day)         3.63±1.170        3.87±1.214      3.73±1.19       0.296

Values are presented as number (%) or mean±standard deviation.

Hb, hemoglobin.
